208 related articles for article (PubMed ID: 3518721)
1. Reactivation of nerve agent inhibited human acetylcholinesterases by HI-6 and obidoxime.
Puu G; Artursson E; Bucht G
Biochem Pharmacol; 1986 May; 35(9):1505-10. PubMed ID: 3518721
[TBL] [Abstract][Full Text] [Related]
2. Reactivation of organophosphate-inhibited human AChE by combinations of obidoxime and HI 6 in vitro.
Worek F; Aurbek N; Thiermann H
J Appl Toxicol; 2007; 27(6):582-8. PubMed ID: 17370251
[TBL] [Abstract][Full Text] [Related]
3. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro.
Kuca K; Jun D; Bajgar J
Drug Chem Toxicol; 2007; 30(1):31-40. PubMed ID: 17364862
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
Worek F; Koller M; Thiermann H; Wille T
Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
[TBL] [Abstract][Full Text] [Related]
5. In vitro reactivation potency of acetylcholinesterase reactivators--K074 and K075--to reactivate tabun-inhibited human brain cholinesterases.
Kuca K; Cabal J; Jun D; Musilek K
Neurotox Res; 2007 Feb; 11(2):101-6. PubMed ID: 17449453
[TBL] [Abstract][Full Text] [Related]
6. Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
Jun D; Kuca K; Picha J; Koleckar V; Marek J
Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504
[TBL] [Abstract][Full Text] [Related]
7. In vitro reactivation of acetylcholinesterase using the oxime K027.
Kuca K; Kassa J
Vet Hum Toxicol; 2004 Feb; 46(1):15-8. PubMed ID: 14748409
[TBL] [Abstract][Full Text] [Related]
8. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
[TBL] [Abstract][Full Text] [Related]
9. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
Kassa J; Jun D; Kuca K
J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
[TBL] [Abstract][Full Text] [Related]
10. Pseudocatalytic scavenging of the nerve agent VX with human blood components and the oximes obidoxime and HI-6.
Wille T; von der Wellen J; Thiermann H; Worek F
Arch Toxicol; 2017 Mar; 91(3):1309-1318. PubMed ID: 27358236
[TBL] [Abstract][Full Text] [Related]
11. In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human.
Clement JG; Erhardt N
Arch Toxicol; 1994; 68(10):648-55. PubMed ID: 7857205
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
Kassa J; Bajgar J
Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
[TBL] [Abstract][Full Text] [Related]
14. Restoration of nerve agent inhibited muscle force production in human intercostal muscle strips with HI 6.
Seeger T; Niessen KV; Langer P; Gerhardus J; Worek F; Friess H; Bumm R; Mihaljevic AL; Thiermann H
Toxicol Lett; 2011 Sep; 206(1):72-6. PubMed ID: 21803135
[TBL] [Abstract][Full Text] [Related]
15. Reactivating potency of obidoxime, pralidoxime, HI 6 and HLö 7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds.
Worek F; Widmann R; Knopff O; Szinicz L
Arch Toxicol; 1998 Mar; 72(4):237-43. PubMed ID: 9587020
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.
Kuca K; Jun D
J Med Toxicol; 2006 Dec; 2(4):141-6. PubMed ID: 18072133
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the reactivating and therapeutic efficacy of newly developed oximes (K347, K628) with commonly used oximes (obidoxime, HI-6) against tabun in rats and mice.
Kassa J; Karasova JZ; Kuca K; Musilek K
Drug Chem Toxicol; 2010 Jul; 33(3):227-32. PubMed ID: 20429807
[TBL] [Abstract][Full Text] [Related]
18. A structure-activity analysis of the variation in oxime efficacy against nerve agents.
Maxwell DM; Koplovitz I; Worek F; Sweeney RE
Toxicol Appl Pharmacol; 2008 Sep; 231(2):157-64. PubMed ID: 18508103
[TBL] [Abstract][Full Text] [Related]
19. A comparison of tabun-inhibited rat brain acetylcholinesterase reactivation by three oximes (HI-6, obidoxime, and K048) in vivo detected by biochemical and histochemical techniques.
Bajgar J; Hajek P; Zdarova JK; Kassa J; Paseka A; Slizova D; Krs O; Kuca K; Jun D; Fusek J; Capek L
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):790-7. PubMed ID: 21054236
[TBL] [Abstract][Full Text] [Related]
20. The reactivating and therapeutic efficacy of oximes to counteract Russian VX poisonings.
Kassa J; Jun D; Kuca K
Int J Toxicol; 2006; 25(5):397-401. PubMed ID: 16940011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
